Financial News · Live Terminal

Page 41 of 167

Global-E Online Insider Sold Shares Worth $259,411, According to a Recent SEC Filing

Nir Debbi, Director, President, on July 14, 2026, sold 6,642 shares in Global-E Online (GLBE) for $259,411. Following the Form 4 filing with the SEC, Debbi has control over a total of 4,527,657 ordinary shares of the company, with 4,527,657 shares held directly.SEC Filing:https://www.sec.gov/Archives/edgar/data/1835963/000119312526304733/xslF345X05/ownership.xml

$GLBE

Insider Trading29d ago

Kroger Insider Sold Shares Worth $1,764,000, According to a Recent SEC Filing

Yael Cosset, Executive Vice President, on July 14, 2026, sold 30,000 shares in Kroger (KR) for $1,764,000. Following the Form 4 filing with the SEC, Cosset has control over a total of 127,868 common shares of the company, with 127,868 shares held directly.SEC Filing:https://www.sec.gov/Archives/edgar/data/56873/000169441826000008/xslF345X05/ownership.xmlPrice: $56.95, Change: $-1.79, Percent Change: -3.05%

$KR

Insider Trading29d ago

Copart Insider Sold Shares Worth $2,204,000, According to a Recent SEC Filing

Daniel J Englander, Director, on July 13, 2026, sold 80,000 shares in Copart (CPRT) for $2,204,000. Following the Form 4 filing with the SEC, Englander has control over a total of 235,352 common shares of the company, with 235,352 controlled indirectly.SEC Filing:https://www.sec.gov/Archives/edgar/data/900075/000119312526304271/xslF345X05/ownership.xmlPrice: $27.88, Change: $+0.36, Percent Change: +1.31%

$CPRT

Insider Trading29d ago

Beone Medicines Insider Sold Shares Worth $18,256,808, According to a Recent SEC Filing

John Oyler, Director, Chief Executive Officer, on July 10, 2026, sold 60,218 shares in Beone Medicines (ONC) for $18,256,808. Following the Form 4 filing with the SEC, Oyler has control over a total of 51,637,304 ordinary shares of the company, with 5,605,310 shares held directly and 46,031,994 controlled indirectly.SEC Filing:https://www.sec.gov/Archives/edgar/data/1651308/000104204726000011/xslF345X05/wk-form4_1784078719.xml

$ONC

Insider Trading29d ago

Beone Medicines Insider Sold Shares Worth $44,626,424, According to a Recent SEC Filing

John Oyler, Director, Chief Executive Officer, on July 14, 2026, sold 145,861 shares in Beone Medicines (ONC) for $44,626,424. Following the Form 4 filing with the SEC, Oyler has control over a total of 51,477,911 ordinary shares of the company, with 5,445,917 shares held directly and 46,031,994 controlled indirectly.SEC Filing:https://www.sec.gov/Archives/edgar/data/1651308/000104204726000013/xslF345X05/wk-form4_1784078797.xml

$ONC

Insider Trading29d ago

Procore Technologies Insider Sold Shares Worth $2,463,531, According to a Recent SEC Filing

Craig F. Courtemanche Jr., Director, on July 10, 2026, sold 56,122 shares in Procore Technologies (PCOR) for $2,463,531. Following the Form 4 filing with the SEC, Courtemanche has control over a total of 5,318,730 shares of the company, with 919,704 shares held directly and 4,399,026 controlled indirectly.SEC Filing:https://www.sec.gov/Archives/edgar/data/1611052/000162828026048229/xslF345X05/wk-form4_1784078490.xml

$PCOR

Insider Trading29d ago

Grab Holdings Insider Sold Shares Worth $1,563,960, According to a Recent SEC Filing

Anthony Ping Tan Yeow, Director and Chief Executive Officer, on July 10, 2026, sold 400,000 shares in Grab Holdings (GRAB) for $1,563,960. Following the Form 4 filing with the SEC, Tan has control over a total of 28,498 Class A ordinary shares of the company, with 28,498 shares held directly.SEC Filing:https://www.sec.gov/Archives/edgar/data/1855612/000185561226000117/xslF345X05/wk-form4_1784076680.xml

$GRAB

Insider Trading29d ago

Broadcom Insider Sold Shares Worth $10,033,225, According to a Recent SEC Filing

Mark David Brazeal, Chief Legal and Corporate Affairs Officer, on July 10, 2026, sold 25,000 shares in Broadcom (AVGO) for $10,033,225. Following the Form 4 filing with the SEC, Brazeal has control over a total of 194,989 common shares of the company, with 194,989 shares held directly.SEC Filing:https://www.sec.gov/Archives/edgar/data/1730168/000173016826000070/xslF345X05/wk-form4_1784075021.xml

$AVGO

Insider Trading29d ago

Liquidia Insider Sold Shares Worth $2,520,683, According to a Recent SEC Filing

Roger Jeffs, Director and Chief Executive Officer, on July 10, 2026, sold 35,249 shares in Liquidia (LQDA) for $2,520,683. Following the Form 4 filing with the SEC, Jeffs has control over a total of 2,218,688 common shares of the company, with 1,130,426 shares held directly and 1,088,262 controlled indirectly.SEC Filing:https://www.sec.gov/Archives/edgar/data/1819576/000110465926083619/xslF345X05/tm2620529-6_4seq1.xml

$LQDA

Insider Trading29d ago

Liquidia Insider Sold Shares Worth $1,460,965, According to a Recent SEC Filing

Michael Kaseta, Chief Financial Officer and Chief Operating Officer, on July 10, 2026, sold 20,430 shares in Liquidia (LQDA) for $1,460,965. Following the Form 4 filing with the SEC, Kaseta has control over a total of 345,805 common shares of the company, with 345,805 shares held directly.SEC Filing:https://www.sec.gov/Archives/edgar/data/1819576/000110465926083620/xslF345X05/tm2620529-7_4seq1.xml

$LQDA

Insider Trading29d ago

Liquidia Insider Sold Shares Worth $1,053,926, According to a Recent SEC Filing

Russell Schundler, General Counsel, on July 10, 2026, sold 14,738 shares in Liquidia (LQDA) for $1,053,926. Following the Form 4 filing with the SEC, Schundler has control over a total of 620,462 common shares of the company, with 605,962 shares held directly and 14,500 controlled indirectly.SEC Filing:https://www.sec.gov/Archives/edgar/data/1819576/000110465926083617/xslF345X05/tm2620529-4_4seq1.xml

$LQDA

Insider Trading29d ago

Arista Networks Insider Sold Shares Worth $43,907,278, According to a Recent SEC Filing

Jayshree Ullal, Director, Chief Executive Officer and Chairperson, on July 10, 2026, sold 234,578 shares in Arista Networks (ANET) for $43,907,278. Following the Form 4 filing with the SEC, Ullal has control over a total of 27,493,341 common shares of the company, with 9,917 shares held directly and 27,483,424 controlled indirectly.SEC Filing:https://www.sec.gov/Archives/edgar/data/1596532/000159653226000162/xslF345X05/edgardoc.xml

$ANET

Insider Trading29d ago

Disc Medicine Insider Sold Shares Worth $2,473,780, According to a Recent SEC Filing

John D Quisel, Director and Chief Executive Officer, on July 13, 2026, sold 33,000 shares in Disc Medicine (IRON) for $2,473,780. Following the Form 4 filing with the SEC, Quisel has control over a total of 226,064 common shares of the company, with 226,064 shares held directly.SEC Filing:https://www.sec.gov/Archives/edgar/data/1816736/000119312526303535/xslF345X05/ownership.xml

$IRON

Insider Trading29d ago

Applied Optoelectronics Insider Sold Shares Worth $488,360, According to a Recent SEC Filing

Stefan J. Murry, Chief Financial Officer, on July 10, 2026, sold 4,000 shares in Applied Optoelectronics (AAOI) for $488,360. Following the Form 4 filing with the SEC, Murry has control over a total of 380,576 common shares of the company, with 380,576 shares held directly.SEC Filing:https://www.sec.gov/Archives/edgar/data/1158114/000168316826005532/xslF345X05/ownership.xml

$AAOI

Insider Trading29d ago

Alignment Healthcare Insider Sold Shares Worth $5,919,361, According to a Recent SEC Filing

John E Kao, Director, Chief Executive Officer, on July 10, 2026, sold 298,000 shares in Alignment Healthcare (ALHC) for $5,919,361. Following the Form 4 filing with the SEC, Kao has control over a total of 2,697,509 common shares of the company, with 1,608,743 shares held directly and 1,088,766 controlled indirectly.SEC Filing:https://www.sec.gov/Archives/edgar/data/1832466/000162828026048170/xslF345X05/wk-form4_1784062026.xml

$ALHC

Insider Trading29d ago

United Therapeutics Insider Sold Shares Worth $5,091,949, According to a Recent SEC Filing

Martine A Rothblatt, Director, Chairperson & CEO, on July 13, 2026, sold 9,500 shares in United Therapeutics (UTHR) for $5,091,949. Following the Form 4 filing with the SEC, Rothblatt has control over a total of 668,728 common shares of the company, with 40,513 shares held directly and 628,215 controlled indirectly.SEC Filing:https://www.sec.gov/Archives/edgar/data/1082554/000110657826000097/xslF345X05/primarydocument.xml

$UTHR

Insider Trading30d ago

ICF International Insider Sold Shares Worth $993,918, According to a Recent SEC Filing

John Wasson, Director, CEO & President, on July 13, 2026, sold 12,411 shares in ICF International (ICFI) for $993,918. Following the Form 4 filing with the SEC, Wasson has control over a total of 101,760 common shares of the company, with 21,582 shares held directly and 80,178 controlled indirectly.SEC Filing:https://www.sec.gov/Archives/edgar/data/1362004/000122520826006600/xslF345X05/doc4.xml

$ICFI

Insider Trading30d ago

Miami International Holdings Insider Sold Shares Worth $1,175,440, According to a Recent SEC Filing

Barbara J. Comly, Executive Vice President, General Counsel & Corporate Secretary, on July 13, 2026, sold 28,000 shares in Miami International Holdings (MIAX) for $1,175,440. Following the Form 4 filing with the SEC, Comly has control over a total of 882,984 common shares of the company, with 882,984 shares held directly.SEC Filing:https://www.sec.gov/Archives/edgar/data/1438472/000162828026048154/xslF345X05/wk-form4_1784059634.xml

$MIAX

Insider Trading30d ago

Cytokinetics Insider Sold Shares Worth $615,150, According to a Recent SEC Filing

Robert I Blum, Director, President & CEO, on July 13, 2026, sold 7,500 shares in Cytokinetics (CYTK) for $615,150. Following the Form 4 filing with the SEC, Blum has control over a total of 381,986 common shares of the company, with 377,820 shares held directly and 4,166 controlled indirectly.SEC Filing:https://www.sec.gov/Archives/edgar/data/1061983/000106198326000077/xslF345X05/form4.xmlPrice: $81.68, Change: $-0.56, Percent Change: -0.68%

$CYTK

Insider Trading30d ago

Lam Research Insider Sold Shares Worth $6,124,470, According to a Recent SEC Filing

Abhijit Y Talwalkar, Director, on July 13, 2026, sold 18,282 shares in Lam Research (LRCX) for $6,124,470. Following the Form 4 filing with the SEC, Talwalkar has control over a total of 87,142 common shares of the company, with 87,142 shares held directly.SEC Filing:https://www.sec.gov/Archives/edgar/data/707549/000131606526000012/xslF345X05/wk-form4_1784048170.xmlPrice: $346.59, Change: $+16.67, Percent Change: +5.05%

$LRCX

Showing 801-820 of 3329